Related Experiment Videos
[Hyperlipoproteinemia, risk indicators and ischemic heart disease]
Insights
Men with stable angina pectoris and a positive coronary score had significantly more risk indicators for heart disease than those with a negative score. Hyperlipoproteinaemia phenotypes were associated with varying numbers of these indicators.
Area of Science:
- Cardiology
- Preventive Medicine
- Metabolic Disorders
Context:
- Ischaemic heart disease, specifically stable angina pectoris, affects a significant number of men.
- Risk factor assessment is crucial for managing cardiovascular health.
- Coronary scoring systems aid in stratifying cardiac risk.
Purpose:
- To analyze the incidence of cardiovascular risk indicators in men with stable angina pectoris based on their coronary score.
- To compare the number of risk indicators between men with positive and negative coronary scores.
- To investigate the association between specific hyperlipoproteinaemia phenotypes and the number of risk indicators.
Summary:
- A study compared 120 men with stable angina pectoris and a positive coronary score to 30 men with a negative coronary score.
- The group with a positive coronary score exhibited a significantly higher mean number of risk indicators (4.9) compared to the control group (1.7).
- Among patients with a positive coronary score, hyperlipoproteinaemia IIb phenotype showed the highest mean number of risk indicators (5.4).
Impact:
- Findings highlight the substantial burden of risk factors in men with established ischaemic heart disease and positive coronary scores.
- This underscores the importance of comprehensive risk factor management in this patient population.
- Identifying specific hyperlipoproteinaemia phenotypes associated with a higher risk burden can inform targeted preventive strategies.
Abstract:
The authors analyzed the incidence of risk indicators in a group of 120 men with ischaemic heart disease, type stable angina pectoris, with a positive coronary score in a group of 30 men with a negative coronary score. The mean age of the probands was 35 +/- 7.539 years, in men of the control group 42.1 +/- 8.891 years. The mean number of risk indicators in the group of probands was 4.9 +/- 2.100, in the control group 1.7 +/- 1.067 (p less than 0.001). The highest number of risk indicators was found in probands with the phenotype of hyperlipoproteinaemia IIb - 5.4 +/- 0.756, as compared with 4.8 +/- 0.861 in probands with the phenotype of hyperlipoproteinaemia IIa, and 4.4 +/- 2.300 in men with phenotype of hyperlipoproteinaemia IV.